Cargando…
339. OPAT Outcomes in Patients with Immunocompromise
BACKGROUND: Outpatient parenteral antimicrobial therapy (OPAT) allows patients to complete intravenous (IV) or high risk oral medications outside the acute inpatient setting. Data regarding OPAT in patients with immunocompromise (PWIC) are sparse. PWIC represent a vulnerable population due to underl...
Autores principales: | Mahoney, Monica V, Swords, Kyleen, Le Mahajan, Audrey, Alonso, Carolyn D, Larnard, Jeffrey |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10679249/ http://dx.doi.org/10.1093/ofid/ofad500.410 |
Ejemplares similares
-
From sea to shining IV: the current state of OPAT in the United States
por: Larnard, Jeffrey, et al.
Publicado: (2023) -
1923. OPAT or No-PAT? Evaluation of Outpatient Parenteral Antimicrobial Therapy (OPAT) Patients Receiving Daptomycin or Ertapenem for “Ease of Administration”
por: Britt, Rachel S, et al.
Publicado: (2018) -
619. Current State of Infectious Diseases Pharmacist OPAT/COpAT Practice in the United States
por: Rivera, Christina G, et al.
Publicado: (2021) -
P13 Every patient who could have OPAT, should have OPAT—the importance of data
por: Williams, Steph, et al.
Publicado: (2022) -
Comparison of Outcomes in Outpatient Parenteral Antimicrobial Therapy (OPAT) Patients Receiving Vancomycin vs. Non-Vancomycin Anti-MRSA Therapy
por: Stoneking, Carolyn, et al.
Publicado: (2017)